Beyond Air (XAIR) Cash from Investing Activities Growth (1y) (2017 - 2026)
Powered by 
Analysis
Beyond Air (XAIR) Cash from Investing Activities Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | -12.26% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | -44.16% |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 618.55% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 0.00% |
| 10 | Beyond Air | 2.25 Mn | -8.67 Mn | 225,000.00 | -19.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.97% |
| Mar 31, 2026 | -117.32% |
| Dec 31, 2025 | 41.72% |
| Sep 30, 2025 | -96.99% |
| Jun 30, 2025 | -81.50% |
| Mar 31, 2025 | 254.83% |
| Dec 31, 2024 | -913.25% |
| Sep 30, 2024 | 1,013.24% |
| Jun 30, 2024 | 132.26% |
| Mar 31, 2024 | -118.81% |
| Dec 31, 2023 | -80.56% |
| Sep 30, 2023 | 94.73% |
| Jun 30, 2023 | -3,556.44% |
| Mar 31, 2023 | 2,713.57% |
| Dec 31, 2022 | 1,147.26% |
| Sep 30, 2022 | -4,948.27% |
| Jun 30, 2022 | -877.78% |
| Mar 31, 2022 | -1,595.00% |
| Dec 31, 2021 | -201.44% |
| Sep 30, 2021 | -36.42% |